88553807 - RENMAB

Information

• Trademark
• 88553807

• Source

• Serial Number

  88553807

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 31 - Grains and agricultural, horticultural and forestry products not included in other classes
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 31, 2019
  5 years ago

• Transaction Date

  May 20, 2025
  16 days ago

• Status Date

  November 19, 2024
  6 months ago

• Published for Opposition Date

  August 17, 2021
  3 years ago

• Location Date

  May 13, 2025
  23 days ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  CROWLEY, SEAN

• Attorney Docket Number

  44835044001

  Attorney Name

  CYNTHIA JOHNSON WALDEN

  Law Office Assigned Location Code

  M70

• Owners

  • BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD

Case File Statements

• GS0051: (Based on Intent To Use) Medical immunoassay reagent derived from experimental animals; medical biological preparations for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; drugs for treating cancer, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; medicines for human purposes, namely, for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; biochemical drugs for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; immunologic stimulants for medical use for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; bulk drugs for the treatment of diseases, namely, Active Biopharmaceutical Ingredients derived from experimental animals; medical diagnostic preparation, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals
• TR0010: The wording "RENMAB" has no meaning in a foreign language.
• GS0011: (Based on 44(e)) Chemical additives for insecticides; nitrogen fertilizer; food preservative chemicals; biological preparations not for medical or veterinary use; radioactive elements for scientific purposes; diagnostic preparations not for medical or veterinary use; protein in raw material form for scientific and medical research, and industrial use; plasticizers being industrial chemicals; industrial adhesives; industrial chemicals, not for medical use
• GS0311: (Based on 44(e)) Live experimental animal; live animals; live poultry; live hamster; live swine; living trees; plant seeds; hay; living plants
• GS0421: (Based on 44(e)) Drug development services for others provided via a platform for antibody discovery that features experimental animal research; drug evaluations being pharmaceutical research provided via a platform for antibody discovery that features experimental animal research; pharmaceutical research provided via a platform for antibody discovery that features experimental animal research; Implementation of early assessment in new drug development fields for others, involving experimental animals, to support the development by others of pharmaceutical preparations and medicines; development of pharmaceutical preparations and medicines provided via a platform for antibody discovery that features experimental animal research; clinical trials being pharmaceutical and scientific research services provided via a platform for antibody discovery that features experimental animal research; package design; research and development of antibodies provided via a platform for antibody discovery that features experimental animal research; research and development of new products for others provided via a platform for antibody discovery that features experimental animal research; products development for others provided via a platform for antibody discovery that features experimental animal research; consulting services in biotechnology development fields involving experimental animal research and antibodies discovered from the same, the aforementioned also provided via a platform for antibody discovery that features experimental animal research; biological research and analyses provided via a platform for antibody discovery that features experimental animal research; biochemistry research and analyses provided via a platform for antibody discovery that features experimental animal research; biotechnology research provided via a platform for antibody discovery that features experimental animal research

Case File Event Statements

• 8/3/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 8/14/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/28/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/5/2019 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/5/2019 - 5 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/5/2019 - 5 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/5/2020 - 5 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/8/2020 - 5 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 5/12/2020 - 5 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/12/2020 - 5 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/29/2020 - 5 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 5/29/2020 - 5 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 5/29/2020 - 5 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 12/2/2020 - 4 years ago

  14 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 1/5/2021 - 4 years ago

  15 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 1/5/2021 - 4 years ago

  16 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 1/5/2021 - 4 years ago

  17 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 2/17/2021 - 4 years ago

  18 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 7/6/2021 - 3 years ago

  19 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 7/9/2021 - 3 years ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/9/2021 - 3 years ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/9/2021 - 3 years ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/28/2021 - 3 years ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/17/2021 - 3 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/17/2021 - 3 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/15/2021 - 3 years ago

  26 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 2/14/2022 - 3 years ago

  27 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I

• 10/21/2024 - 7 months ago

  28 - OPPOSITION DISMISSED NO. 999999 Type: OP.D

• 10/21/2024 - 7 months ago

  30 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN

• 10/21/2024 - 7 months ago

  29 - OPPOSITION TERMINATED NO. 999999 Type: OP.T

• 11/19/2024 - 6 months ago

  31 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 5/1/2025 - a month ago

  32 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 5/18/2025 - 18 days ago

  34 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 5/19/2025 - 17 days ago

  35 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/13/2025 - 23 days ago

  33 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN